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Abstract
Carbohydrate restriction as a strategy for control of obesity is based on two effects: a behavioral effect,
spontaneous reduction in caloric intake and a metabolic effect, an apparent reduction in energy efficiency,
greater weight loss per calorie consumed. Variable energy efficiency is established in many contexts
(hormonal imbalance, weight regain and knock-out experiments in animal models), but in the area of the
effect of macronutrient composition on weight loss, controversy remains. Resistance to the idea comes
from a perception that variable weight loss on isocaloric diets would somehow violate the laws of
thermodynamics, that is, only caloric intake is important ("a calorie is a calorie"). Previous explanations of
how the phenomenon occurs, based on equilibrium thermodynamics, emphasized the inefficiencies
introduced by substrate cycling and requirements for increased gluconeogenesis. Living systems, however,
are maintained far from equilibrium, and metabolism is controlled by the regulation of the rates of
enzymatic reactions. The principles of nonequilibrium thermodynamics which emphasize kinetic fluxes as
well as thermodynamic forces should therefore also be considered.
Here we review the principles of nonequilibrium thermodynamics and provide an approach to the problem
of maintenance and change in body mass by recasting the problem of TAG accumulation and breakdown
in the adipocyte in the language of nonequilibrium thermodynamics. We describe adipocyte physiology in
terms of cycling between an efficient storage mode and a dissipative mode. Experimentally, this is
measured in the rate of fatty acid flux and fatty acid oxidation. Hormonal levels controlled by changes in
dietary carbohydrate regulate the relative contributions of the efficient and dissipative parts of the cycle.
While no experiment exists that measures all relevant variables, the model is supported by evidence in the
literature that 1) dietary carbohydrate, via its effect on hormone levels controls fatty acid flux and
oxidation, 2) the rate of lipolysis is a primary target of insulin, postprandial, and 3) chronic carbohydrate-
restricted diets reduce the levels of plasma TAG in response to a single meal.
In summary, we propose that, in isocaloric diets of different macronutrient composition, there is variable
flux of stored TAG controlled by the kinetic effects of insulin and other hormones. Because the fatty acid-
TAG cycle never comes to equilibrium, net gain or loss is possible. The greater weight loss on
carbohydrate restricted diets, popularly referred to as metabolic advantage can thus be understood in
terms of the principles of nonequilibrium thermodynamics and is a consequence of the dynamic nature of
bioenergetics where it is important to consider kinetic as well as thermodynamic variables.
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Background
Dietary carbohydrate provides both an energy source and,
through its effects on insulin and other hormones, regula-
tory control of metabolism. In the context of obesity, dia-
betes and related pathologic states, it is argued by many
researchers that the level of carbohydrate, by its hormonal
effects, controls the disposition of nutrient intake beyond
simple caloric balance [1-11]. From this point of view, fat
plays a relatively passive role and the deleterious effects of
high dietary fat are expected only if there is sufficient die-
tary carbohydrate to provide the hormonal state in which
the fat will be stored rather than oxidized. In its practical
application, the principle has given rise to several forms of
popular diet strategies which have in common some
degree of carbohydrate restriction [12-14] or effective gly-
cemic level [3,15]. Experimentally, protocols based on
carbohydrate restriction do as well or better than fat
reduction for weight loss (reviews: [16-18]), but because
they are somewhat iconoclastic with respect to official die-
tary recommendations and because they derive from the
popular diets where discourse is heated, they remain con-
troversial. The extent to which carbohydrate restriction is
successful as a strategy for control of obesity or diabetes
can be attributed to two effects. The strategy frequently
leads to a behavioral effect, a spontaneous reduction in
caloric intake as seen in ad lib comparisons. There is also
a metabolic effect, an apparent reduction in energy effi-
ciency seen in isocaloric comparisons, popularly referred
to as metabolic advantage. The two are not necessarily
independent: an association between thermogenesis, a
reflection of inefficiency, and satiety has been established
by Westerterp, et al., for example [19].
Experimental demonstrations of energy inefficiency in
humans have recently been summarized [16,17,20] and
the phenomenon has been demonstrated in animal mod-
els (e.g., ref. [21] and, most dramatically ref. [22]). This
metabolic effect, however, is not universally accepted as a
major component in human experiments, oddly even by
investigators who have provided experimental support
[23-26]. Variable energy efficiency, however, is known in
many contexts: hormonal imbalance [27,28], intensive
insulin therapy [29], studies of weight regain [30,31] and
particularly knock-out experiments in animals [32-34].
Experiments demonstrating variable energy efficiency in
the context of weight loss, however, remain controversial
because of the difficulty in validating compliance in die-
tary interventions and because of a resistance to what is
perceived as a violation of thermodynamics, that is, an
intuitive feeling that, in the end, everything must even
out. Thus, progress in this field still depends on a proper
understanding of caloric efficiency and a description of
how energy balance can account for differences in weight
loss in isocaloric comparisons.
We have previously described how different isocaloric
diets are actually expected to have different effects on
metabolism and therefore on body mass [16,35,36]. Our
previous arguments were largely based on equilibrium
thermodynamics because this is most familiar. However,
living systems, and in particular, TAG stores in adipocytes,
are maintained far from equilibrium and the rates of
breakdown of such high energy compounds are regulated
by the kinetics of the enzymes that catalyze hydrolysis and
re-synthesis. Because the system is maintained far from
equilibrium, energy measurements provide values of (∂G/
∂ξ)T,P where ξ is the reaction progress coordinate and the
path-independence of state variables, that is, ∆G values
measured in a calorimeter do not necessarily apply [37].
In essence, then, the problem is as much one of rates as of
free energy. Much progress has been made in the develop-
ment of nonequilibrium thermodynamics for the study of
metabolism although there is no universally accepted
approach ([38-40] and references therein) and the current
work is intended to provide a first step towards develop-
ing the problem of energy efficiency in response to dietary
macronutrients.
Here we review the basic ideas of nonequilibrium thermo-
dynamics and provide an approach to the problem of
maintenance and change in body mass following these
ideas. The emphasis is on flux of metabolites in adipose
tissue since, in the end, this is the major reflection of
energy balance and obesity. The work has several goals:
1. To recast the problem of TAG accumulation and break-
down in the adipocyte in the language of nonequilibrium
thermodynamics. In particular, we want to describe adi-
pocyte physiology in terms of cycling between an efficient
storage mode and a dissipative mode. Experimentally, this
is reflected in the rate of fatty acid flux and fatty acid oxi-
dation.
2. To provide a plausible mechanism for how different
efficiencies of isocaloric diets can be accounted for by
changes in kinetics. To show that hormonal levels control-
led by changes in carbohydrate intake determine the rela-
tive contributions of the efficient and dissipative parts of
the TAG-FA cycle.
Overall, the model is intended to provide a conceptual
framework for energy efficiency in nutrition and to point
the way to future research. We feel that the approach has
general implications as well and is tied to the philosophi-
cal position espoused by Prigogine and followers in
emphasizing the dynamic nature of physical processes,
that is, the need to consider kinetics as well as thermody-
namics [39,41-44].Theoretical Biology and Medical Modelling 2007, 4:27 http://www.tbiomed.com/content/4/1/27
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We emphasize that metabolic efficiency is not always seen
in diet comparisons. A thermodynamic analysis, however,
shows that inefficiency is to be expected and it is the cases
where "a calorie is a calorie" that need to be explained: it
is the unique characteristics of living systems – mainte-
nance of a steady-state through tightly controlled feed-
back systems – not general physical laws that accounts for
energy balance when it is found. Practically speaking, the
importance of obesity and other metabolic disorders
makes it important to see what the requirements are to
break out of these stable states.
Nonequilibrium thermodynamics
It is traditional to separate thermodynamics and kinetics
but such a division applies strictly only to equilibrium sys-
tems [41,45]. Systems that are far from equilibrium may
undergo chemical reactions that never attain equilibrium
and are characterized by the flux of material as well as
energy. In a dietary intervention, the flux of material must
be integrated over time to determine the total change in
weight or fat loss. Thus, accumulated changes may be con-
trolled by the presence of a catalyst or other factors that
affect the rate of reaction.
In the case at hand, adipocytes cycle between states of
greater or lower net breakdown of fat (lipolysis and rees-
terification) depending on the hormonal state which, in
turn, is dependent on the macronutrient composition of
the diet. A hypothetical scheme for changes in adipocyte
TAG and a proposal for how TAG gain or loss could be dif-
ferent for isocaloric diets with different levels of insulin is
shown in Figure 1. Under normal control conditions of
weight maintenance, the breakdown and utilization of
TAG by lipolysis and oxidation is balanced by the re-syn-
thesis from food intake. Assuming, for simplicity. an
instantaneous spike in food at meals, the curves represent
the net flow of material (possibly through several TAG-FA
cycles) within the adipocyte. In a coarse-grained analysis,
the integral over time of the fluctuations between different
states, measures the change in stored TAG in the time of a
dietary experiment. The average is stable, that is, appears
as weight maintenance. If now each meal is maintained at
constant calories but there is an increase in the percentage
of carbohydrate leading to higher insulin levels, the
lipases may be reduced in activity (blue line in Figure 1).
The rate of re-synthesis of TAG is less perturbed by the ele-
vated insulin [46] and indeed may go the other way. The
system may cycle between states, which, while they never
come to equilibrium, have the net affect of producing
changes in the direction of accumulation of TAG.
In carbohydrate restriction, the decrease in carbohydrate
may be accompanied by an increase in dietary fat and the
relative effect on rate of TAG accumulation due to disinhi-
bition of lipolysis vs the effect of increased substrate will
determine the efficiency. As noted below, experiments in
the literature [47] show that after chronic exposure to a
low carbohydrate diet (higher dietary TAG), the plasma
levels of TAG following a high fat meal are reduced com-
pared to controls. Of course, replacing dietary carbohy-
drate with dietary protein at constant lipid will be
consistent with the model in the absence of compensating
effects.
In these cases, the integrated change in TAG over the
course of a day (or several days) will no longer be zero. In
this way, two diets may lead to different weight gain (as
indicated by accretion of fat), even though they have the
same number of calories, simply because they affect hor-
monal levels differently. An analysis based on rates sug-
gests further that a new steady state may be obtained in
which TAG may be maintained at a higher or lower level
even if the hormonal state returns to one that does not
lead to further change. The cell may then relax from one
steady state to another, the observed macroscopic weight
gain or loss. The goal here is to ask what would it take to
produce behavior like that in Figure 1.
For minor perturbations, there will be compensating
effects of competing pathways (increase in insulin secre-
tion due to fatty acid production [48,49], for example)
and one can expect, insofar as the model corresponds to
reality, there may be a threshold effect. This is reflected in
the emphasis on extreme carbohydrate reduction in the
early phases of popular weight loss diets [12-14]. We
emphasize that all of the potential sources of metabolic
inefficiency – increased reliance on gluconeogenesis and
consequent increased protein turnover, up-regulation of
uncoupling proteins – described previously [16,36] may
still be operative but the net change in fat stores must be
Hypothetical kinetics of fat storage and hydrolysis Figure 1
Hypothetical kinetics of fat storage and hydrolysis. 
Model for the effect of insulin on efficiency of storage. Black 
line indicates response under conditions of weight mainte-
nance. Blue line shows the effect of added insulin on hor-
mone sensitive lipase activity.Theoretical Biology and Medical Modelling 2007, 4:27 http://www.tbiomed.com/content/4/1/27
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the final common output if body mass is to undergo
change.
Formalism of nonequilibrium thermodynamics
For systems that are not at equilibrium, changes in
entropy will drive the system towards equilibrium. If the
system is close to equilibrium or, as in the case here, there
is a small change in the total free energy – only a small
fraction of TAG is actually hydrolyzed in the course of a
day – then the change in entropy will be due to dSe, the
flux of entropy that is exchanged with the environment
and dSi, that due to the irreversible effect of the chemical
reaction [41,50,51]. We are then interested in the rate of
entropy production, Φ, due to chemical reactions at con-
stant T and P:
Φ = dSi/dt = - (1/T) ΣN µk dnk/dt (1)
In nonequilibrium thermodynamics, overall flux of
entropy is considered as a product of forces (derivative of
the potential), Xk and flows Jk, all forces and flows vanish-
ing at equilibrium. In a chemical system, the force Xk is
defined as the negative of the chemical potential of the
kth reaction, sometimes referred to as the affinity A = -
(∂G/∂ξ)T,P where ξ is the extent of chemical reaction. In
other words, a positive sign of × indicates spontaneous
forward driving force. The force, then, depends on the
concentration of reactants and products, the standard free
energy and the extent of reaction. It is worth noting that
for the systems like the adipocyte that are maintained far
from equilibrium the distinction between ∆G values and
(∂G/∂ξ)T,P noted by other authors [37] is important, that
is, the simple additivity of state variables that underlies
the idea that all calories are equivalent, is not valid.
The flows, Jk, are identified with the flux of the kth reac-
tion. The flux of fatty acid in an adipocyte, for example, J1
= vlipolysis + vsynthesis, the sum of breakdown and synthesis
rates for TAG. In the phenomenologic approach of non-
equilibrium thermodynamics, the forces and flows may
be the sum of several individual processes.
In applying the principles of nonequilibrium thermody-
namics, the analysis will be simplified if we make the
assumption that the fluxes are linear functions of the
forces, in analogy with similar linear equations such as
Fick's law of diffusion (diffusion is a linear function of the
concentration gradient), or Ohm's law (current is a linear
function of the potential). The proportionality constant
Lkj is called the phenomenological coefficient.
Jk = Σn LkjXj  (2)
Although the general requirement that condition (2) hold
is that the system be close to equilibrium, the linear
approximation is often observed to be appropriate for sys-
tems very far from equilibrium, subject to stabilizing feed-
back and in enzymatic systems operating in the range of
substrate concentrations that are close to KM [52,53]. Fur-
ther discussion is found in references [54-56]. Whereas
the assumption of linearity is reasonable for the current
model where small perturbations far from equilibrium
occur in a region of high substrate, in the end, it is a work-
ing assumption and experimental tests of the model will
ultimately determine if the assumption is justified.
Qualitative features of the adipocyte model and 
comparison to glycolysis
F igure 2 shows a simple model that is proposed for adi-
pose tissue metabolism under conditions bearing on
changes in body mass. The flux of TAG (1) represents the
net accumulation or output with respect to the cell itself.
This process driven by (2) the input of glycerol-3-phos-
phate from glycolysis or glyceroneogenesis and (3) fatty
acid (FA) from plasma FA. The high energy form of the
cycle, TAG, is stored. From the point of view of the organ-
ism, it is the FA output that provides fuel for oxidation
and cell metabolism. This output may be taken as analo-
gous to the system load as it is usually described in non-
equilibrium thermodynamics. Oxidation and FA uptake
are largely controlled independently, that is, the adipocyte
system has high output conductance and low input con-
ductance, that is, by analogy with an electronic system, is
an ideal amplifier. Because there is effectively no load on
the system and overall metabolic effect is simply to reduce
the affinity of fatty acid, the analysis is greatly simplified.
The flux of FA, J3 is of general physiologic importance and
is the most experimentally accessible of the relevant
parameters.
In the comparison of different diets, an additional com-
ponent is (4) input of fatty acid from TAG-containing
lipoproteins. Our treatment of the problem is to consider
fluxes in the absence of this input since that is how it is
usually described in the literature and then to consider the
effect of input from lipoproteins as a perturbation. Focus-
ing on the reaction in the absence of lipoprotein input,
the overall relations of fluxes and flows:
J1 = L11X1 + L12X2  (3)
J2 = L21X1 + L22X2  (4)
J3 = L13X1 + L33X3  (5)
As an example of the application of these principles,
Aledo, et al. addressed the negative correlation between
glycolytic flux and intracellular ATP concentration in
yeast, the so-called ATP paradox [54,57,58]. The paradox
was resolved by showing that if ATP-consuming pathways
are more sensitive to glucose than the glycolytic pathway,
the cell can switch from an efficient (ATP-conserving) to a
dissipative (ATP-utilizing) regime [54,58]. The dissipative
regime offers higher output at high glucose cost, whereasTheoretical Biology and Medical Modelling 2007, 4:27 http://www.tbiomed.com/content/4/1/27
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the efficient regime has higher accumulation of ATP but
lower glycolytic flux.
In the adipocyte model, periodic switching between dissi-
pative and conservative regimes is meant to describe the
dynamic cycling of TAG. The goal in development of the
model is to show the constraints on the system for conser-
vation of fat mass, and conversely, how isocaloric dietary
inputs of different composition might plausibly bring
about weight gain or loss, that is, how efficiency is regu-
lated in the TAG-FA cycle and the activity of the reactants.
In essence, we want to know what it would take for the
blue line in Figure 1 to occur.
The major controlling variables will be the Lij, the phe-
nomenologic constants which depend on hormonal lev-
els, and the thermodynamic activity of plasma triglyceride
(supplying fatty acid). Looking ahead, the simplest appli-
cation will be the effect of replacing dietary carbohydrate
with dietary protein at constant lipid where a semi-quan-
titative prediction can be made. In the most general case,
however, we also want to know the relative impact of
insulin reduction on the Lij (reduced lipolysis rate) com-
pared to the increase in thermodynamic activity (X4) due
to increased dietary fat.
The variables as they apply to the adipocyte model are as
follows:
X1 = the output force is the affinity of the lipolysis-TAG
synthesis cycle. The analysis can be simplified by the
assumption that lipolysis of available TAG (and possibly
re-synthesis) in an adipocyte occurs at a heterogeneous
interface. We can therefore take the thermodynamic activ-
ity of TAG as 1, that is, although other concentrations may
influence X1, the amount of TAG will not. (The contribu-
tion of TAG activity is unlikely to change in any case since
perturbations in TAG concentrations are extremely small
compared to the total stored TAG).
X1 = -RT (ln (Keq)FA-TAG - ln ([FA]3 [glyc-3-P]/[TAG]) = - 3 
RT ln (([FA] [glyc-3-P]/K')
X2 = the driving force for supply of glycerol-3-phosphate
whose major term is normally the availability of carbohy-
drate. Under conditions of carbohydrate restriction, how-
ever, there is also an increase in glyceroneogenesis from
protein [59,60].
X3 = = the driving force for supply of fatty acid from cellu-
lar TAG.
X4 = the force due to the supply of fatty acid from lipopro-
teins (chylomicrons and VLDL).
In the approach taken here,
L11, L12 are the sensitivities of the flux of TAG to the levels
of TAG and the levels of substrate (glycerol-3-phosphate)
which depend primarily on the hormonal levels (via
phosphorylation of the lipases and other enzymes). It is
generally assumed on theoretical grounds (Onsager rela-
tion) that L12 = L21 although this has to actually be estab-
lished for systems that are not close to equilibrium.
L22 is the sensitivity of the glycerol-3-phosphate flux to the
availability of carbohydrate (or other sources) which may
also be controlled by hormonal levels.
Although somewhat beyond the level of analysis pre-
sented here, it is worth noting some of the derived param-
eter that are traditional in a NET analysis. The degree of
coupling, q = L12 /√L11L22 is a dimensionless parameter
that indicates how tightly the output process is coupled to
the driver process [55] and takes on values from 0 to 1 in
the forward direction. In the model in Figure 2, q will vary
with different subjects and different metabolic states, in
particular, is strongly under the control of insulin.
The phenomenological stoichiometry is defined as Z =
(√L11/L22)
It should be noted that L11, L12 and L22 and the derived
parameters, q and Z, in general, are where the enzymatic
activity and the effect of hormones reside. It is important
to emphasize that many important variables, such as
coenzyme levels are hidden in the phenomenologic con-
stants. For the adipocyte Z = 1, that is, TAG synthesis is
tightly coupled to glycerol-3-P production. These parame-
ters hold the promise to quantify insulin resistance, at
least in the adipocyte.
The experimental parameters that are most frequently
determined in the literature are the rates of appearance in
Model for adipocyte metabolism Figure 2
Model for adipocyte metabolism. See text for details.Theoretical Biology and Medical Modelling 2007, 4:27 http://www.tbiomed.com/content/4/1/27
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the blood of fatty acid and glycerol, traditionally written
Ra (FA) and Ra (glycerol), and the total rate of TAG oxida-
tion (largely oxidation in non-adipocyte), denoted here as
ROX. For the simple two compartment model considered
here, there are four species, adipocyte TAG, plasma TAG,
FA and CO2 (from oxidation).
The goal is to re-cast the problem of metabolism and reg-
ulation of body mass in the formalism of nonequilibrium
thermodynamics, or more simply, in a way that empha-
sizes rates in addition to energetics. Applying the tradi-
tional measurements above leads to particularly simple
form. From conservation of carbon mass of fatty acid spe-
cies, we can write for the mass fluxes:
0 = d(FA)/dt + d(TAG)/dt + d(CO2)/dt = Ra (FA) + J1 + ROX 
+ J4
or J1 = - (ROX + Ra (FA) + J4)( 6 )
J3 = Ra (FA) (7)
Although no experiment in the literature has been done
that would allow for a complete quantitative test of the
model, further analysis can support the value of a non-
equilibrium approach in understanding variable effi-
ciency in weight loss experiments. Experiments
comparing the effect of different macronutrient composi-
tion, for example, can allow us to look at the effects on
TAG accumulation (J1) without explicit analysis of the
individual reactions. Results from the literature that sup-
port the underlying thesis show that 1) fatty acid flux and
oxidation (ROX + Ra (FA), eq. (6)), follow the levels of die-
tary carbohydrate, 2) the effect of carbohydrate is
expressed in the regulation of insulin levels, 3) lipolysis is
the primary target of insulin, 4) the availability of sub-
strate affects efficiency, 5) insulin increases J4 and finally,
6) chronic diet can affect the force X4 and thereby the
response to dietary input in a single experiment. In the
following sections, we consider these in turn. The net
effect is that accumulated time-dependent changes due to
carbohydrate intake control the efficiency of fat storage
and we consider that a nonequilibrium thermodynamic
approach allows clear justification as to how variable
weight gain can be expected on isocaloric diets.
Fatty acid flux and oxidation follow the levels of dietary 
carbohydrate
Similarity of starvation and carbohydrate restriction
Over the years, several investigators have made the obser-
vation that the metabolic response to carbohydrate restric-
tion resembles the response to starvation, in particular, for
the current model, increased fatty acid mobilization and
oxidation [61-65]. Perhaps the best example is an elegant
study by Klein & Wolfe [65] comparing responses of sub-
jects on an 84 hour fast to the same subjects on a similar
fast in which lipids were infused at a level equal to resting
energy requirements. Table 1 shows that the levels of glu-
cose, insulin, the rates of appearance of fatty acid and fat
oxidation, ROX + Ra (FA), were similar in the two groups.
For comparison to equation (6), the molar fluxes would
have to be converted to mass and the role of J4 would have
to be considered explicitly. In fact, as measured here, J4 is
subsumed in the rate of fatty acid appearance and appears
to have little effect despite large differences in X4. These
rather dramatic results were summarized by the authors as
demonstrating that "carbohydrate restriction, not the
presence of a negative energy balance, is responsible for
initiating the metabolic response to fasting." It might be
said that this was the fundamental observation for under-
standing the role of carbohydrates in energy balance and
the need for a kinetic rather than equilibrium thermody-
namic analysis. The controlling variables are presumed to
be carbohydrate itself which provides substrate for glyc-
erol-3-P synthesis and insulin which will affect the phe-
nomenologic constants. Bisschop, et al. [62] showed a
similar increase in FA rate of appearance and oxidation in
a low carbohydrate, high fat diet (CHO:Lipid:Protein =
2:83:15) compared to either a high carbohydrate
(85:0:15) or control (44:41:15) diets, and there is agree-
ment with Klein & Wolfe's data (Table 1). Considering the
difference in protocol, the similarity of the response to
carbohydrate restriction, fasting and fasting + lipid is very
good. Although the subjects in Klein & Wolfe's study lost
comparable amounts of weight in the two procedures, the
short duration and the substantial changes in body water
make it difficult to accurately determine whether TAG
storage follows the calculated value of J1 [65]. It is impor-
tant to point out that in Bisschop's experiment, fatty acid
oxidation does not keep up with the increase in dietary
TAG but according to equations (6) and (7), the flux of
TAG is increasing in the direction of breakdown of TAG
and, again, explicit inclusion of J4 would further bias the
results in that direction.
Although it would obviously be difficult to carry out
experiments for long periods of time in humans, studies
by Tomé's group have shown that rats fed a high fat diet
without carbohydrate ate less and also gained less weight
per calorie consumed than rats fed a high fat diet that
included carbohydrate [21]. Similar results have recently
been published by Kennedy, et al. have shown that a high
fat/ketogenic diet could reverse the obesity induced by an
isocaloric high fat diet that also contained sucrose [22].
The principle that the level of dietary TAG plays a passive
role and that carbohydrate restriction is controlling sug-
gests that evidence from the older literature showing
weight loss on very high fat diets [66] might be worth re-
examining. These were presumably not followed up
because they were so counter-intuitive.Theoretical Biology and Medical Modelling 2007, 4:27 http://www.tbiomed.com/content/4/1/27
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Glucose flux regulates TAG flux
Wolfe and Peters [67] measured the response to infusions
of glucose in humans. The data shown in Table 2 indicate
that the flux of glucose regulates the rate of TAG synthesis
largely through the inhibition of lipolysis. The effect of
glucose, in turn, is presumed to rest primarily with the
effect of insulin.
The effect of carbohydrate is expressed in the regulation 
of insulin levels
Lipolysis is the primary target of insulin
It is well established that the primary effect of insulin,
both kinetically and in terms of physiologic effect is on
the inhibition of lipolysis and there is a large literature
studying this effect (Review: [68]). In the language of non-
equilibrium thermodynamics, this is expressed in the phe-
nomenologic constant, L11. Campbell, for example,
studied fatty acid metabolism in humans infused intrave-
nously with insulin [46]. Figure 3 shows the decline in
fatty acid flux as the plasma insulin is increased. Oxida-
tion of fatty acid was also inhibited but by a much smaller
amount, from 2.7 to 0.9 µmol/kg lean body mass/min.
The total rate of primary reesterification (from fatty acid
that is not released to the plasma after lipolysis) was sim-
ilarly increased. Insulin levels further increase the uptake
of plasma TAG due to increase lipoprotein lipase (LPL)
activity. Frayn and coworkers[69,70] have shown how the
combination of LPL and lipolysis leads to increase in flux
towards TAG storage. Again, the relative hormonal reduc-
tion in lipolysis and any increase in esterification due to
mass action if plasma TAG is increased will determine if
net TAG accumulation will occur. The importance of insu-
lin can be seen in studies in which insulin secretion is
indirectly inhibited via administration of a somatostatin
antagonist octreotide. This intervention leads to a reduc-
tion in fat mass [6]. Conversely, it has long been known
that chronic insulin therapy for diabetes leads to weight
gain and decreased flux of fatty acids compared to isoca-
loric controls.
The most dramatic if abstract demonstration of the poten-
tial effect of carbohydrate restriction on insulin stimula-
tion of fat cells comes from the study of the adipose-
specific insulin receptor knockout mice FIRKO mouse of
Bluher & Kahn [32,71]. These animals have a knockout of
the insulin receptor specific to the adipocyte. Widely dis-
cussed because of their increased longevity they also show
greatly reduced efficiency in the storage of lipid and are
significantly thinner than the wild type even though both
groups consumed the same amount of food (Figure 4).
Insulin Flux
The flux of insulin for diabetic patients under two dietary
conditions is shown in Figure 5. A consistently lower level
of insulin throughout the day is seen under conditions of
lower carbohydrate intake. In addition, Such behavior has
been measured frequently in the literature. Chronic carbo-
hydrate restriction means that this reduced insulin never
catches up with control. The study from Gannon & Nuttal
[72] was carried out under conditions of weight mainte-
nance so that there is presumably a compensating fatty
acid oxidation but it is clear that insulin flux is controlled
by dietary carbohydrate which, in turn, reduces the flux of
fatty acid.
Table 2: The effect of glucose flux on calculated TAG flux
Ra(glucose) (µmol/kg/min) fat oxidation (µmol/kg/min) Ra FA (µmol/kg/min) - SUM ∆ SUM
Basal 3.74 5.78 9.52 -
5.6 3.14 4.96 8.10 1.42
22.2 3.48 3.25 6.73 2.79
44.4 1.99 2.43 4.42 5.10
Data from reference [67].
Table 1: Similarity of the effects of starvation and carbohydrate restriction on fatty acid flux and oxidation
Study/subjects Glucose FA Rox Ra FA - (ROX + RaFA)
(mg/dl) (µmol/l) (µmol/kg/min)
Ref: [62] High CHO 91.8 0.38 0.90 1.52 2.42
control 91.8 0.42 1.25 1.76 3.01
High Fat 77.4 0.75 1.83 2.98 4.81
Ref: [65] Fast 84 h 68 0.92 1.94 0.97 2.91
Fast + Lipid 66 1.02 1.67 1.00 2.67
Data from references [62] and [65].Theoretical Biology and Medical Modelling 2007, 4:27 http://www.tbiomed.com/content/4/1/27
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Availability of substrate affects efficiency
Glycerol-3-phosphate: PEPCK overexpression
The key substrate for TAG synthesis is glycerol-3-phos-
phate. Because adipocytes normally have very low levels
of glycerol kinase, the flux of TAG is dependent on proc-
esses (J2) that supply glycerol-3-phosphate: glycolysis or,
under conditions of starvation or glucose deprivation,
glyceroneogenesis, a truncated form of gluconeogenesis
[59]. These processes are dependent on the composition
of the diet and the hormonal state of the organism. One
approach to separating the effect of glucose from the effect
of glucose-induced insulin, is the genetic manipulation of
the level of enzymes under conditions of low glucose.
Such a strategy allows one to isolate the driving force from
the effects of hormone on the phenomenologic constants,
L22 and L21. Franckhauser [73] overexpressed phosphoe-
nolpyruvate carboxykinase (PEPCK) in mice adipocytes.
Under conditions of starvation, transgenic mice showed
increased glyceroneogenesis which was accompanied by
increased reesterification of free fatty acids (FAs), and a
corresponding decrease in circulating FAs, both reflecting
an increase in stored TAG (Table 3). In fact, the transgenic
mice showed increased adipocyte size and fat mass, and
higher body weight. Insulin sensitivity was preserved.
When fed, nutrient consumption was the same for the
Effect of diet on serum insulin concentration Figure 5
Effect of diet on serum insulin concentration. Mean 
serum insulin concentration before (red) and after (blue) 5 
weeks on a reduced carbohydrate diet (CHO:Lipid:Protein = 
20:50:30) using a randomized crossover design with a 5-week 
washout period. Data from reference [72]. The control diet 
was (55:30:15). As noted in the text, the insulin values are in 
the linear range of the dependence of fatty acid flux on insu-
lin and the pattern roughly proportional to the flux of fatty 
acid.
Effect of insulin on fatty acid flux Figure 3
Effect of insulin on fatty acid flux. Free fatty acid appear-
ance in plasma R(a) were examined in healthy humans infused 
intravenously with insulin. Data from reference [46]. Units 
converted for comparison to figure 5.
Weight change and food intake of the FIRKO mouse Figure 4
Weight change and food intake of the FIRKO mouse. 
Data from reference [71, 88] Adipose-specific insulin recep-
tor knockout (FIRKO) mice have normal or increased food 
intake but are protected from obesity.Theoretical Biology and Medical Modelling 2007, 4:27 http://www.tbiomed.com/content/4/1/27
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experimental animals and the wild type. Thus, the change
in the enzymatic activity of PEPCK affects the accretion of
fat in the absence of any change in caloric intake or change
in hormonal level that normally triggers changes in
PEPCK levels. An overall change in the efficiency of food
utilization is 2-fold for the heterozygotes and almost 4-
fold for the homozygotes.
In similar experiments, Shepherd, et al. [74] overex-
pressed adipocyte GLUT4 in transgenic mice. Body lipid
was increased 2–3 fold in these mice compared to wild-
type and the mutants had increased insulin sensitivity.
Direct comparison to the simple model in Figure 2 is com-
plicated by the fact that the transgenic mice showed fat
cell hyperplasia rather than a simple increase in size.
Dietary fat and the effect of chronic carbohydrate restriction
The key question in the application of the model is the
extent to which lipolysis and other catabolic processes
that are increased by reductions in insulin are compen-
sated for by the increased availability of dietary TAG (X4)
if carbohydrate in the diet is replaced by fat. At this point,
we can consider the process indicated by J4, the influx of
plasma FA from plasma TAG, as a perturbation on overall
TAG storage. The activity of lipoprotein lipase (J4) is
increased by higher insulin and will be reduced by chronic
carbohydrate restriction [75]. The effect of chronic diet on
the response to dietary fat challenge can provide further
data on this point. Sharman, et al. [47] showed that six
weeks on a low carbohydrate ketogenic diet led to a sub-
stantially reduced postprandial serum triacylglycerol
(TAG) response in normal-weight men (Figure 6). The
low carbohydrate group, in distinction to controls,
showed drastically reduced (-34 %) insulin levels. Thus,
despite the higher fat intake, the rate of lipolysis increased
and the contribution of activity of TAG (X4) went down.
The bottom line: efficient and dissipative modes
While no experiment in the literature measures all the rel-
evant variables, comparisons of Figures 3, 5 and 6 give a
sense of the difference in time dependent responses on
low carbohydrate and high carbohydrate (high insulin)
diets. The individual components that contribute are as
follows:
1. Rate of lipolysis. Insulin represses lipolysis as shown in
Figure 3. This is true even in insulin-resistant states such as
diabetes. Carbohydrate restriction reduces insulin fluxes
as indicated in Figure 5.
2. Figure 6 shows that the effect of chronic carbohydrate
restriction compared to controls is to reduce plasma trig-
lycerides (X4) in response to a fat challenge, reducing the
activity of FA in the carbohydrate-restricted state com-
pared to the higher carbohydrate state.
3. Lipoprotein lipase is known to be up-regulated by
higher insulin increasing the flux of FA into the adipocyte
(J4) under conditions of high carbohydrate.
4. Carbohydrate represses per cent fat oxidation.
Thus, all of the differences in high and low insulin states
are in the direction of efficient modes in the former and
toward more dissipative modes in the latter.
Effect of chronic diets on postprandial response to high fat  meal Figure 6
Effect of chronic diets on postprandial response to 
high fat meal. Responses to high fat meal before and after 6 
weeks on low carbohydrate (< 10% energy) ketogenic diet in 
overweight men. Data from reference [47].
Table 3: Effect of overexpression of PEPCK of starved mice on feeding
Starved mice PEPCK activity (%) (J2) pyruvate -> 
glycerol (cpm/mg 
prot/2 hr)
(J1) FA 
reesterification 
(mmol/mg prot/2 
hr)
J1/J2 (mmol/cpm) FAT PAD Wt. 
(mg)
Food consumed 
mg ± SE
control 100 300 300 1.0 400 3.3 ± 0.1
hetero-PEPCK 400 650 550 1.18 800 3.2 ± 0.1
homo-PEPCK 1300 750 620 1.21 1500 3.4 ± 0.1
Data from reference [73].Theoretical Biology and Medical Modelling 2007, 4:27 http://www.tbiomed.com/content/4/1/27
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As a guide to future research, then, the continuous moni-
toring of FA flux and oxidation, or other variables that
allow determination of TAG flux can be done with current
technology and it is possible to test the role of kinetic reg-
ulation in different weight loss strategies and to rational-
ize variable efficiency. It is important to point out that a
thermodynamic analysis explains the potential for the
metabolic advantage for particular diets but can, as well,
point the way to identifying other factors that maintain
homeostasis. In other words, isocaloric diets do not
always show differences in efficiency and the thermody-
namic analysis suggests that it is as important to explain
cases where metabolic advantage does not occur as those
where it does.
Conductance matching
A metabolic scheme of the type considered here is tradi-
tionally evaluated in terms of the effect of the demand on
the output by the load, or conductance matching by anal-
ogy with electronic systems [54,58]. The assumptions of
the model in Figure 2 is that there is effectively no load on
the adipocyte: output of fatty acid and its subsequent uti-
lization by other tissues, are independently regulated and
the adipocyte, in effect, has very high output conductance,
that is, supplies whatever fatty acid is required. Wolfe and
coworkers [76-78] have emphasized the extent to which
glucose controls fatty acid metabolism rather than the
other way around as originally suggested in the Randle
cycle [79,80]. From the perspective of further metabolic
analysis, the adipocyte may be considered a discrete mod-
ular element and could be patched into a larger network.
Discussion
Variable metabolic efficiency due to the macronutrient
composition of the diet is plausibly explained in terms of
nonequilibrium thermodynamics by a shift in the cycling
between dissipative lipolytic modes and efficient storage
modes. Such a mechanism is consistent with experimental
data on the effect of diet on metabolism. The nonequilib-
rium thermodynamic approach and the application to the
FA-TAG cycle may raise general questions about metabo-
lism.
Fatty acid flux, insulin resistance
There is an increasing perception that circulating fatty
acids are critical in metabolic responses and, in particular,
in the development of insulin resistance and type 2 diabe-
tes [81-83]. The effect of insulin resistance on the disinhi-
bition of lipolysis and an increase in fatty acid flux may be
as important for the adipocyte as the effect on glucose
uptake. In combination, the two effects may reduce TAG
storage and may represent a down-regulation in response
to excess insulin. As such, it may be thought of as benefi-
cial for obesity and, at the same time, suggests that reduc-
tion in insulin directly or via carbohydrate restriction will
improve insulin resistance.
The increase in circulating fatty acid remains problemati-
cal in that, whereas it does indicate that less TAG is stored,
it is generally considered deleterious and may lead to
peripheral insulin resistance. In addition, fatty acids are
known to stimulate insulin secretion. On the other hand,
the effects of high plasma FA may be different under con-
ditions of low carbohydrate: FA-induced insulin secretion,
for example, is strongly dependent on carbohydrate levels
[48] and is probably not a factor at all if plasma glucose is
low. In practice, carbohydrate restriction improves insulin
resistance and the increased fatty acids may be considered
a reflection of a more general paradox: it is observed that
fatty acid levels are increased in obesity[68] and references
therein), diabetes and insulin resistance but are also ele-
vated by those conditions that mediate against these con-
ditions: exercise, starvation and carbohydrate restriction.
It is also paradoxical that the TZD's increase insulin sensi-
tivity but also pre-dispose to obesity. The latter effect has
been shown to be due at least partly to the increase in glyc-
eroneogenesis (X2) [59,84]. It could also be argued that
the high levels indicate that FA is not being taken up by
peripheral tissues as happens in insulin-resistant states. A
recent review by Westman argues similarly that a so-called
glycolytic pressure controls the disposition of fatty acid as
fuel in muscles [85].
General perspective
Animal models provide very clear-cut demonstrations of
inefficiency as a function of macronutrient composition
and therefore it seems there is no theoretical barrier to
accepting demonstrations in humans where ideal control
is not possible. The driving force for TAG flux in the pro-
posed model is the availability of carbohydrate and the
key regulating phenomenologic constant depends on
insulin and other hormones. Of course, the system is
going to be subject to other cells and processes. De novo
fatty acid synthesis is a significant effect. Moreover, this
simple model makes no attempt to account for compen-
satory processes and the nonlinear effects that are ulti-
mately expected in complex biological systems. For
example, hepatic production of β-hydroxybutyrate, which
increases twenty-fold during very low carbohydrate diets,
inhibits lipolysis [86], likely blunting the effects of
reduced insulin concentrations.  The increased fatty acid
flux under carbohydrate restriction will lead to increased
insulin secretion and, at some point, these process would
have to be added back into the model. 
Relation to previous arguments on reduced energy 
efficiency
We previously pointed out a number of errors in the idea
that weight regulation is necessarily independent of dietTheoretical Biology and Medical Modelling 2007, 4:27 http://www.tbiomed.com/content/4/1/27
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composition (and therefore insulin levels) [16,35,36]. We
proposed several mechanisms and, in a practical sense, all
of these – increased gluconeogenesis and associated
increased protein turnover, increased mitochondrial
uncoupling and increased substrate cycling – must be
reflected in the flux of TAG if fat loss is to be effected. We
have also pointed out that in a dietary intervention it is
important to be specific about changes in fat mass not
simply weight loss [87]. The mechanism is ultimately
through fatty acid oxidation which, again, will be under
separate control of glucose and hormones.
From a theoretical standpoint, the simplest objection to
the idea that calorimeter values are sufficient to under-
stand processing of food is that it assumes that no process
other than complete oxidation takes place, that is, that
metabolic reactions are the same as calorimeter reactions.
This is obviously not generally true since living organisms
use other reactants and make all kinds of products, pro-
teins, ATP, etc. In comparing two diets of different macro-
nutrient composition each diet itself must conform to the
first law, but because they may be carrying out different
overall chemical reactions, there is no requirement that
the energy changes are the same in the two biological reac-
tions just because the reference calorimeter values are the
same. In addition, it is expected that different pathways
will have different efficiencies as dictated by the second
law. Thus, it is not thermodynamics, but the special char-
acteristics of living systems that explain why energy bal-
ance is usually observed. Under most conditions, a steady
state can be attained in which oxidation of food to CO2
and water is the major process, and the differences
between the diets in the other reactions are small.
Finally, as noted above, application of thermodynamic
laws is limited in systems that do not come to equilib-
rium. This has been described in the literature as the inap-
propriate use of ∆G values [37] when what is really
measured under conditions where equilibrium is not
attained is (∂G/∂ξ)T,P where ξ is the reaction progress coor-
dinate. In the end, a thorough going analysis of the poten-
tial for inefficiency must consider nonequilibrium
conditions.
Conclusion
Emphasis on kinetics and nonequilibrium thermodynam-
ics provides a conceptual framework for understanding
the effect of macronutrient composition on maintenance
and change of body mass and possibly for analysis of adi-
pocyte metabolism in general. The simple model pre-
sented is intended to be consistent with a general shift
away from equilibrium thermodynamics and towards a
more dynamic analysis of cellular processes.
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